Management of Vancomycin-Associated Fever
Diagnostic Approach
- The Infectious Diseases Society of America recommends considering vancomycin as a potential cause of drug-related fever, particularly if fever persists beyond 48-72 hours without microbiologic evidence of gram-positive infection 1, 2
- The society suggests evaluating for other noninfectious causes, such as thrombophlebitis, underlying malignancy, or blood resorption from hematoma, when fever persists or develops during vancomycin therapy 1
- Breakthrough infections should be considered, with new cultures and symptom-directed diagnostic testing 1
Management Algorithm
- The Infectious Diseases Society of America recommends discontinuing vancomycin if blood cultures have been negative for 48 hours and no pathogenic gram-positive organisms are identified 1, 2, 3
- Persistent fever alone in a hemodynamically stable patient is not an indication to continue vancomycin, with a randomized trial demonstrating no difference in time-to-defervescence when vancomycin was added versus placebo for persistent fever in neutropenic patients 1, 2, 4
- Vancomycin should only be maintained for specific documented indications, including positive blood cultures for gram-positive bacteria, hemodynamic instability or severe sepsis, documented pneumonia, clinically suspected serious catheter-related infection, skin or soft-tissue infection, or known colonization with MRSA, VRE, or penicillin-resistant S. pneumoniae 3, 5, 6
Alternative Gram-Positive Coverage
- If gram-positive coverage remains necessary after vancomycin discontinuation, the Infectious Diseases Society of America suggests considering alternative agents, such as linezolid, daptomycin, or teicoplanin (where available) 6, 7, 8
- Linezolid is preferred for VRE, with monitoring for hematologic toxicity 6, 7, 8
- Daptomycin is an acceptable alternative, with note of potential cross-resistance with vancomycin-nonsusceptible strains 6, 7, 8